Advances in Cancer Research
- 1st Edition, Volume 95 - July 24, 2006
- Editors: George F. Vande Woude, George Klein
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 0 0 6 6 9 5 - 7
- eBook ISBN:9 7 8 - 0 - 0 8 - 0 4 6 4 4 8 - 0
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and origin… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteThe Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics including NY-ESO-1: review of an immunogenic tumor antigen; Order, disorder, death: lessons from a superorganism; Control of differentiation in progression of epithelial tumors; Cancer vaccines: preclinical studies and novel strategies; Clinical results of vaccine therapy for cancer: learning from history for improving the future; Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell based cancer vaccines; NK cell receptors as tools in cancer immunotherapy; Innate immune recognition and suppression of tumors; Inhibitors of the HSP90 molecular chaperone: current status.
Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology and molecular biology.
NY-ESO-1: Review of an Immunogenic Tumor Antigen.
Order, Disorder, Death: Lessons from a Superorganism.
Control of Differentiation in Progression of Epithelial Tumors.
Cancer Vaccines: Preclinical Studies and Novel Strategies.
Clinical Results of Vaccine Therapy for Cancer: Learning from History for Improving the Future.
Immunodominance and Immunodomination: Critical Factors in Developing Effective CD8+ T-Cell Based Cancer Vaccines.
NK Cell Receptors as Tools in Cancer Immunotherapy.
Innate Immune Recognition and Suppression of Tumors.
Inhibitors of the HSP90 Molecular Chaperone: Current Status.
Order, Disorder, Death: Lessons from a Superorganism.
Control of Differentiation in Progression of Epithelial Tumors.
Cancer Vaccines: Preclinical Studies and Novel Strategies.
Clinical Results of Vaccine Therapy for Cancer: Learning from History for Improving the Future.
Immunodominance and Immunodomination: Critical Factors in Developing Effective CD8+ T-Cell Based Cancer Vaccines.
NK Cell Receptors as Tools in Cancer Immunotherapy.
Innate Immune Recognition and Suppression of Tumors.
Inhibitors of the HSP90 Molecular Chaperone: Current Status.
- No. of pages: 376
- Language: English
- Edition: 1
- Volume: 95
- Published: July 24, 2006
- Imprint: Academic Press
- Hardback ISBN: 9780120066957
- eBook ISBN: 9780080464480
GV
George F. Vande Woude
Affiliations and expertise
Director, Van Andel Research Institute, Grand Rapids, MI, USA
NCI-Frederick Cancer Research Facility Frederick, Maryland
ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, MarylandGK
George Klein
Affiliations and expertise
Karolinska Insitutet, Stockholm, SwedenRead Advances in Cancer Research on ScienceDirect